Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma
Background 18F-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography (PET) is
a functional imaging modality based on glucose metabolism. The correlation between EGFR …
a functional imaging modality based on glucose metabolism. The correlation between EGFR …
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
CT Huang, RF Yen, MF Cheng, YC Hsu, PF Wei… - Medical Oncology, 2010 - Springer
Objective Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …
EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis
L Chen, Y Zhou, X Tang, C Yang… - International …, 2019 - spandidos-publications.com
Abstract [18F] fluoro‑2‑deoxyglucose (FDG) positron emission tomography (PET)‑computed
tomography (CT) is a functional imaging modality based on glucose metabolism. The …
tomography (CT) is a functional imaging modality based on glucose metabolism. The …
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status
D Wang, M Zhang, X Gao, L Yu - PLoS One, 2016 - journals.plos.org
The study objective was to retrospectively analyze the metabolic variables derived from 18 F-
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung …
L Zhu, G Yin, W Chen, X Li, X Yu, X Zhu… - Thoracic …, 2019 - Wiley Online Library
Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …
A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
X Sun, Z Xiao, G Chen, Z Han, Y Liu, C Zhang… - Science translational …, 2018 - science.org
Tumor heterogeneity and changes in epidermal growth factor receptor (EGFR) mutation
status over time challenge the design of effective EGFR tyrosine kinase inhibitor (TKI) …
status over time challenge the design of effective EGFR tyrosine kinase inhibitor (TKI) …
Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung …
B Yang, QG Wang, M Lu, Y Ge, YJ Zheng, H Zhu… - Frontiers in …, 2019 - frontiersin.org
Purpose: This study assessed the ability of metabolic parameters from
18Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG …
18Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG …
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer
A Shi, J Wang, Y Wang, G Guo, C Fan, J Liu - Annals of Nuclear Medicine, 2022 - Springer
Objectives To explore the value of multiple metabolic and heterogeneity parameters of 2-
deoxy-2-[fluorine-18] fluoro-D-glucose positron emission tomography/computed tomography …
deoxy-2-[fluorine-18] fluoro-D-glucose positron emission tomography/computed tomography …
Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
IK Hong, JM Lee, IK Hwang, SS Paik… - Cancer management …, 2020 - Taylor & Francis
Purpose The clinical implications of the metabolic parameters of 18F-fluorodeoxyglucose
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …
18F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line …
YE Huang, YH Tsai, YJ Huang, JH Lung, KW Ho… - Cancers, 2022 - mdpi.com
Simple Summary Epithelial growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
the first-line therapy for patients with advanced-stage lung adenocarcinoma with EGFR …
the first-line therapy for patients with advanced-stage lung adenocarcinoma with EGFR …
相关搜索
- lung adenocarcinoma mutation status
- lung adenocarcinoma correlation of egfr
- lung adenocarcinoma pet ct
- parameters of 18f fdg pet
- lung adenocarcinoma egfr mutations
- lung adenocarcinoma uptake value
- lung adenocarcinoma metabolic parameters
- lung adenocarcinoma fluorodeoxyglucose positron
- lung cancer patient management
- lung adenocarcinoma tomography image
- patients with advanced lung adenocarcinoma
- lung adenocarcinoma functional parameters
- small cell lung cancer
- lung adenocarcinoma prognostic value
- lung adenocarcinomas egfr tkis
- lung adenocarcinomas outcomes in patients